Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Molecular Pharmaceutics|May 23, 2022
PET Imaging of Bromodomain and Extra-Terminal Domain Inhibitors for the Noninvasive Assessment of Metabolic Changes in the Liver and Brain of Early-Stage Alcoholic Liver DiseaseZude Chen, Riwei Yang, Yulong Xu, et al.
Nature Communications|January 11, 2022
Suppressing electrolyte-lithium metal reactivity via Li<sup>+</sup>-desolvation in uniform nano-porous separatorLi Sheng, Qianqian Wang, Xiang Liu, et al.
BMC Medicine|October 26, 2023
A new histone deacetylase inhibitor remodels the tumor microenvironment by deletion of polymorphonuclear myeloid-derived suppressor cells and sensitizes prostate cancer to immunotherapyZude Chen, Xiaoshuang Yang, Zugen Chen, et al.
The Journal of Experimental Medicine|September 16, 2020
Molecular imaging of Alzheimer's disease-related gamma-secretase in mice and nonhuman primatesYulong Xu, Changning Wang, Hsiao-Ying Wey, et al.
Chinese Medicine|August 29, 2022
Quantification of prevalence, clinical characteristics, co-existence, and geographic variations of traditional Chinese medicine diagnostic patterns via latent tree analysis-based differentiation rules among functional dyspepsia patientsLeonard Ho, Yulong Xu, Nevin L Zhang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 28, 2020
Imaging assisted evaluation of antitumor efficacy of a new histone deacetylase inhibitor in the castration-resistant prostate cancerZude Chen, Xiashuang Wang, Xiaoshuang Yang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 26, 2024
Development of a New Positron Emission Tomography Imaging Radioligand Targeting RIPK1 in the Brain and Characterization in Alzheimer's DiseasePing Bai, Yu Lan, Yan Liu, et al.
Nature Communications|May 8, 2026
Efsubaglutide alfa added to metformin improves glycaemia with β-cell functional responses in type 2 diabetes: a randomised, double-blind, placebo-controlled, two-stage adaptive phase 2b/3 trial (SUPER 2)Weiping Jia, Fei Gao, Jingyi Lu, et al.
Diabetologia|November 21, 2025
Efficacy and safety of efsubaglutide alfa in individuals with type 2 diabetes (SUPER1): a randomised, double-blind, placebo-controlled, Phase IIb/III trialDalong Zhu, Jianhua Ma, Weimin Wang, et al.
Pageof 10